Q34516311 | Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008. |
Q35138280 | Impact of pay for performance on prescribing of long-acting reversible contraception in primary care: an interrupted time series study |
Q34715725 | International experience in controlling pharmaceutical expenditure: influencing patients and providers and regulating industry - a systematic review |
Q58696718 | Modelling the cost-effectiveness of pay-for-performance in primary care in the UK |
Q36222903 | Pay-for-performance in the United Kingdom: impact of the quality and outcomes framework: a systematic review. |
Q30399359 | Payment methods for outpatient care facilities |
Q24188018 | Pharmaceutical policies: effects of financial incentives for prescribers |
Q64966246 | Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy. |
Q34071866 | The effects of financial incentives for case finding for depression in patients with diabetes and coronary heart disease: interrupted time series analysis |
Q42674901 | The role of the Quality and Outcomes Framework in the care of long-term conditions: a systematic review. |
Search more.